Centogene N.V.

Products

Category

Product

Brand

Description

Rare Disease Diagnostics: Technologies and Global Markets (PHM227B)

Genetic and multi-omic testing services		A comprehensive genetic testing portfolio with 19,000 genes represented. Key diagnostic tests include NGS panels test for various hereditary and non-hereditary conditions, CentoXome (WES test), and CentoGenome (WGS test) for rare disease diagnosis. CentoMetabolic MOx combines genetic and biochemical testing to deliver a quick and accurate multi-omic diagnosis of rare metabolic disorders.
CentoCloud		The Bioinformatic SaaS Platform is designed to facilitate the rapid bioinformatic analysis and interpretation of NGS data.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.